10 Jan 2022 by admin in UncategorizedComments BioNTech and Crescendo Biologics announce global collaboration to develop multi-specific precision immunotherapies
05 Jan 2022 by admin in UncategorizedComments Eluminex Further Expands Leadership Team and Receives New Awards
13 Dec 2021 by admin in UncategorizedComments RareStone Group & Rhythm Pharmaceuticals Announce Exclusive Licensing Agreement for the Development and Commercialization of IMCIVREE (setmelanotide) in China
12 Dec 2021 by admin in UncategorizedComments NextCure and Collaborators Provide Data on Targets in Development at American Society of Hematology Annual Meeting
10 Dec 2021 by admin in UncategorizedComments Adicet Bio, Inc. Announces Closing of $100 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
09 Dec 2021 by admin in UncategorizedComments Interius BioTherapeutics Announces Granting of US Patent to Support in Vivo Cell-Specific Gene Delivery Platform
07 Dec 2021 by admin in UncategorizedComments Alebund Pharmaceuticals Holds Groundbreaking Ceremony for Yangzhou Research and Production Base
06 Dec 2021 by admin in UncategorizedComments Innoforce Completes Second Tranche of Series A Financing
26 Nov 2021 by admin in UncategorizedComments Crescendo Biologics Wins “Best Established Biotech Company” at the 2021 OBN Awards
21 Nov 2021 by admin in UncategorizedComments Zenas BioPharma Acquires Exclusive Worldwide Rights to Obexelimab from Xencor
18 Nov 2021 by admin in UncategorizedComments Tempest Announces First Patient Dosed with TPST-1495 in Combination with Pembrolizumab
18 Nov 2021 by admin in UncategorizedComments Syros Reports Third Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
18 Nov 2021 by admin in UncategorizedComments Adicet Announces Appointment of Dr. Michael G. Kauffman to the Board of Directors
16 Nov 2021 by admin in UncategorizedComments KIRA PHARMACEUTICALS APPOINTS TERI LOXAM AS CHIEF OPERATING OFFICER AND CHIEF FINANCIAL OFFICER
12 Nov 2021 by admin in UncategorizedComments Adicet Presents Preclinical Data for ADI-002, a GPC3-Targeted Development Candidate for Solid Tumors, at the SITC Annual Meeting
10 Nov 2021 by admin in UncategorizedComments Tempest Reports Third Quarter 2021 Financial Results and Provides Corporate Highlights
10 Nov 2021 by admin in UncategorizedComments Adicet Reports Third Quarter 2021 Financial Results and Provides Business Updates
09 Nov 2021 by admin in UncategorizedComments Design Therapeutics Reports Pipeline Progress and Third Quarter 2021 Results
05 Nov 2021 by admin in UncategorizedComments Syros Reports Third Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
01 Nov 2021 by admin in UncategorizedComments Laronde Expands Board of Directors with Leading Pharmaceutical Executives
20 Oct 2021 by admin in UncategorizedComments Crescendo Biologics announces prestigious new collaboration with The Institute of Cancer Research, London
19 Oct 2021 by admin in UncategorizedComments NextCure Announces Three New Members of its Scientific Advisory Board
13 Oct 2021 by admin in UncategorizedComments Syros Reports Inducement Grant to Chief Financial Officer under Nasdaq Listing Rule 5635(c)(4)
13 Oct 2021 by admin in UncategorizedComments Eluminex Biosciences Announces the Grand Opening of New Global Headquarters and Research and Development Center in Suzhou
12 Oct 2021 by admin in UncategorizedComments Syros Pharmaceuticals Announces Appointment of Jason Haas as Chief Financial Officer
12 Oct 2021 by admin in UncategorizedComments Adicet Announces Promotion of Blake Aftab, Ph.D. to Chief Scientific Officer
07 Oct 2021 by admin in UncategorizedComments NextCure Announces Publication of Preclinical Data for NC410
05 Oct 2021 by admin in UncategorizedComments Pennovation Lab welcomes new tenant Interius BioTherapeutics to its innovation ecosystem
04 Oct 2021 by admin in UncategorizedComments NextCure Announces New Appointments to its Board of Directors
29 Sep 2021 by admin in UncategorizedComments Syros Announces First Patient in Dose Confirmation Study of SY-2101, a Novel Oral Form of Arsenic Trioxide, in Acute Promyelocytic Leukemia
28 Sep 2021 by admin in UncategorizedComments Syros Reports Inducement Grant to Chief Commercial Officer under Nasdaq Listing Rule 5635(c)(4)
27 Sep 2021 by admin in UncategorizedComments Syros Announces Appointment of Conley Chee as Chief Commercial Officer
20 Sep 2021 by admin in UncategorizedComments Tempest Announces First Patient Dosed in Randomized Study Evaluating TPST-1120 in First-Line Regimen for Hepatocellular Carcinoma in Clinical Collaboration with Roche
14 Sep 2021 by admin in UncategorizedComments Alebund Pharmaceuticals Raises $54.5 Million in Series B+ Financing Round to Fuel Development of Renal Disease Treatment
13 Sep 2021 by admin in UncategorizedComments Walking Fish Therapeutics Launches with $50 Million in Series A Financing to Accelerate Development of B Cell Therapies for Multiple Diseases
13 Sep 2021 by admin in UncategorizedComments Tempest Enters into Exclusive License Agreement with the University of California for Novel Cancer Target
13 Sep 2021 by admin in UncategorizedComments Adicet Bio Collaborates with Twist Bioscience to Accelerate Discovery of Gamma Delta T Cell Cancer Therapeutics
10 Sep 2021 by admin in UncategorizedComments Syros Announces Appointment of Deborah Dunsire, M.D., to Its Board of Directors
09 Sep 2021 by admin in UncategorizedComments Syros Announces First Patient Dosed in SELECT-AML-1 Trial of Tamibarotene in Combination with Venetoclax and Azacitidine in Newly Diagnosed Unfit AML
